Andera Partners
- SEC CIK
- 0001757283
- Latest filing
- Jul 22, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 11, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 7
- +2 vs. Q4 2025
- Portfolio value
- $176.9M
- +$308.9K (+0.2%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NYXHNyxoah SA | COMMONSTOCK | 522,057 | $1.52M | 0.9% | +522,057 | New | History |
| ABVXAbivax S.A. | SPONSORED ADS | 78,125 | $8.70M | 4.9% | 00.0% | Unchanged | History |
| IVAInventiva S.A. | ADS | 1,818,181 | $10.1M | 5.7% | 00.0% | Unchanged | History |
| AGMBAgomAb Therapeutics NV | SPONSORED ADS | 1,538,702 | $16.1M | 9.1% | +1,538,702 | New | History |
| MLYSMineralys Therapeutics, Inc. | COM | 1,591,917 | $43.1M | 24.4% | 00.0% | Unchanged | History |
| EVMNEvommune, Inc. | COM SHS | 1,897,362 | $43.6M | 24.7% | 00.0% | Unchanged | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 2,695,192 | $53.7M | 30.4% | +155,086+6.1% | Added | History |